Published on Medical Design Technology (http://www.mdtmag.com)

Home > Abbott gets EU approval of Crohn’s disease drug

Abbott gets EU approval of Crohn’s disease drug

Mass High Tech: The Journal of New England Technology

A drug approved to treat moderately-active Crohn’s disease, a chronic inflammatory bowel disease of the gastrointestinal tract, in the European Union has been approved to treat severely active patients with the disease.

Source URL (retrieved on 05/19/2013 - 1:08am): http://www.mdtmag.com/news/2012/08/abbott-gets-eu-approval-crohn%E2%80%99s-disease-drug